SCHEMBL3229052

SCHEMBL3229052

O=C(O)c1ccccc1C(=O)OC(=O)c1ccccc1C(=O)O.[KH].[NaH]

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.64
ALOX15 P16050 1/20 0.64
AKR1C3 P42330 1/20 0.50
KDM4E B2RXH2 4/20 0.48
HPGD P15428 3/20 0.48
HMGB1 P09429 2/20 0.48
NAPRT Q6XQN6 2/20 0.48
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA4 P22748 1/20 0.48
CA6 P23280 1/20 0.48
CA7 P43166 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
CA9 Q16790 1/20 0.48
CA14 Q9ULX7 1/20 0.48
MAPT P10636 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
POLB P06746 1/20 0.45
HSD17B10 Q99714 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6765311 1.00 ALDH1A1 (0.64) ALDH1A1ALOX15AKR1C3KDM4EHPGD
SCHEMBL7030042 0.98 ALDH1A1 (0.67) ALDH1A1ALOX15AKR1C3KDM4EHPGD
SCHEMBL16585286 0.98 ALDH1A1 (0.67) ALDH1A1ALOX15AKR1C3KDM4EHPGD
SCHEMBL29393238 0.95 ALDH1A1 (0.70) ALDH1A1ALOX15AKR1C3KDM4EHPGD
SCHEMBL248317 0.95 ALDH1A1 (0.70) ALDH1A1ALOX15AKR1C3KDM4EHPGD
SCHEMBL713624 0.95 ALDH1A1 (0.70) ALDH1A1ALOX15AKR1C3KDM4EHPGD
SCHEMBL28132113 0.90 ALDH1A1 (0.56) ALDH1A1ALOX15AKR1C3KDM4EHPGD
Biphenyl SCHEMBL8035806 0.89 ALDH1A1 (0.61) ALDH1A1ALOX15AKR1C3KDM4EHPGD
SCHEMBL6066794 0.89 ALDH1A1 (0.61) ALDH1A1ALOX15AKR1C3KDM4EHPGD
SCHEMBL2834372 0.89 ALDH1A1 (0.61) ALDH1A1ALOX15AKR1C3KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8217172-B2 Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1H-benzo[d]imidazol-2-yl)urea VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-07-10 US disclosed
US-20100063284-A1 SOLID FORMS OF 1-ethyl-3-(5-(5-FLUOROPYRIDIN-3-YL)-7-(PYRIMIDIN-2-YL)-1H-BENZO[D]IMIDAZOL-2-YL)UREA VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063284-A1 SOLID FORMS OF 1-ethyl-3-(5-(5-FLUOROPYRIDIN-3-YL)-7-(PYRIMIDIN-2-YL)-1H-BENZO[D]IMIDAZOL-2-YL)UREA RCC1, UPP1, UACA ALDH1A1 2629/4885ALOX15 4743/4885AKR1C3 4180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.